WO2000003678A3 - Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives - Google Patents

Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives Download PDF

Info

Publication number
WO2000003678A3
WO2000003678A3 PCT/US1999/014129 US9914129W WO0003678A3 WO 2000003678 A3 WO2000003678 A3 WO 2000003678A3 US 9914129 W US9914129 W US 9914129W WO 0003678 A3 WO0003678 A3 WO 0003678A3
Authority
WO
WIPO (PCT)
Prior art keywords
contraception
subcutaneous
medroxyprogesterone acetate
progestogen
estrogen
Prior art date
Application number
PCT/US1999/014129
Other languages
English (en)
Other versions
WO2000003678A2 (fr
Inventor
Koning Gans Hendrik J De
Original Assignee
Upjohn Co
Koning Gans Hendrik J De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Koning Gans Hendrik J De filed Critical Upjohn Co
Priority to AU49579/99A priority Critical patent/AU4957999A/en
Priority to JP2000559813A priority patent/JP2002520346A/ja
Priority to EP99933540A priority patent/EP1098653A2/fr
Publication of WO2000003678A2 publication Critical patent/WO2000003678A2/fr
Publication of WO2000003678A3 publication Critical patent/WO2000003678A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Cette invention a trait à une technique de contraception féminine consistant à administrer par voie sous-cutanée une quantité efficace du point de vue contraceptif d'un agent contraceptif sélectionné dans le groupe constitué par un progestatif et un progestatif associé à un oestrogène.
PCT/US1999/014129 1998-07-17 1999-07-09 Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives WO2000003678A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU49579/99A AU4957999A (en) 1998-07-17 1999-07-09 Subcutaneous medroxyprogesterone acetate for contraception
JP2000559813A JP2002520346A (ja) 1998-07-17 1999-07-09 避妊用皮下メドロキシプロゲステロンアセタート
EP99933540A EP1098653A2 (fr) 1998-07-17 1999-07-09 Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9317198P 1998-07-17 1998-07-17
US10369998P 1998-10-09 1998-10-09
US60/103,699 1998-10-09
US12682499P 1999-03-30 1999-03-30
US60/093,171 1999-03-30
US60/126,824 1999-03-30

Publications (2)

Publication Number Publication Date
WO2000003678A2 WO2000003678A2 (fr) 2000-01-27
WO2000003678A3 true WO2000003678A3 (fr) 2000-11-09

Family

ID=27377447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/014129 WO2000003678A2 (fr) 1998-07-17 1999-07-09 Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives

Country Status (4)

Country Link
EP (1) EP1098653A2 (fr)
JP (1) JP2002520346A (fr)
AU (1) AU4957999A (fr)
WO (1) WO2000003678A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
EP2399566A1 (fr) * 2010-06-28 2011-12-28 Laboratoire HRA Pharma Procédé de contraception une fois par mois

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU686736A1 (ru) * 1977-02-10 1979-09-25 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Способ лечени эндокринных гинекологических заболеваний
SU724127A1 (ru) * 1977-02-10 1980-03-30 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Способ определени функции ичников
EP0129947A2 (fr) * 1983-05-19 1985-01-02 World Health Organisation Compositions contraceptives à base d'esters de levo-norgestrel
EP0303306A1 (fr) * 1987-08-08 1989-02-15 Akzo N.V. Implant contraceptif
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
WO1993000070A1 (fr) * 1991-06-28 1993-01-07 Endorecherche Inc. Androgenes de faible dosage et systemes a liberation regulee

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU686736A1 (ru) * 1977-02-10 1979-09-25 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Способ лечени эндокринных гинекологических заболеваний
SU724127A1 (ru) * 1977-02-10 1980-03-30 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Способ определени функции ичников
EP0129947A2 (fr) * 1983-05-19 1985-01-02 World Health Organisation Compositions contraceptives à base d'esters de levo-norgestrel
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
EP0303306A1 (fr) * 1987-08-08 1989-02-15 Akzo N.V. Implant contraceptif
WO1993000070A1 (fr) * 1991-06-28 1993-01-07 Endorecherche Inc. Androgenes de faible dosage et systemes a liberation regulee

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
COUTINHO E M ET AL: "Conception control by monthly injections of medroxyprogesterone suspension and long-acting oestrogen.", JOURNAL OF REPRODUCTION AND FERTILITY, (1968 MAR) 15 (2) 209-14., XP000904773 *
DATABASE WPI Derwent World Patents Index; AN 1980-36031c, XP002136710, "Endocrine gynaecological disorder treatment- by- injecting oestrogen and progesterone subcutaneously in amounts depending on skin sensitivity." *
DATABASE WPI Derwent World Patents Index; AN 1980-80228c, XP002136709, "Investigating functioning of ovaries - by subcutaneous injections of oestradiol, oestriol, oestrone and progesterone and evaluating skin reaction." *
HALL P ET AL: "Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.", CONTRACEPTION, (1997 DEC) 56 (6) 353-9., XP000904758 *
JEF REYNOLDS: "Martindale, The Extra PHarmacopea", THE ROYAL PHARMACEUTICAL SOCIETY, LONDON, UK, XP002136038 *
SARKAR N.N. ET AL: "Bioavailability of norethindrone in women and rabbits after administration of norethindrone acetate through the subcutaneous route.", EXPERIENTIA, (1982) 38/11 (1345-1346). CODEN: EXPEAM, XP000891845 *

Also Published As

Publication number Publication date
WO2000003678A2 (fr) 2000-01-27
EP1098653A2 (fr) 2001-05-16
JP2002520346A (ja) 2002-07-09
AU4957999A (en) 2000-02-07

Similar Documents

Publication Publication Date Title
WO1999024027A3 (fr) Contraceptifs oraux a base d'anti-oestrogenes associes a un progestatif
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
CA2188907A1 (fr) Compose pour contraception basee sur les oestrogenes naturels
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
AU3000795A (en) Slip-resistant contraceptive male condom
AU7066300A (en) Insertion/deployment catheter system for intrafallopian contraception
HUP9901662A3 (en) Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
CA2420348A1 (fr) Contraceptif vaginal non hormonal
AU2276088A (en) Hormone preparations for hormone replacement therapy and contraceptive method
WO2002051420A3 (fr) Techniques et formulations pour le traitement de dysfonctionnements sexuels chez la femme
CA2243274A1 (fr) Implant contraceptif masculin
EP0065385A3 (fr) Méthodes et compositions pour la contraception intravaginale
CA2487722A1 (fr) Nouveaux esters d'etonogestrel
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
WO1998004246A3 (fr) Contraceptif oral
HK1129564A1 (zh) 基於促孕劑和雌激素的避孕方法
AU4627397A (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
WO2000003678A3 (fr) Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives
BG102682A (en) System for the release of contraceptives having bactericidal and/or antiviral effect
WO2000021511A3 (fr) Acetate de medroxyprogesterone administre par voie sous-cutanee en vue du traitement de la menopause et de l'endometriose
PL324939A1 (en) Steroid compounds of contraceptive and antiosteoportic activity, pharmaceutic composition and method of obtaining 16,17-anelated steroids
AU4043597A (en) Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO2001026603A3 (fr) Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins
WO1999025360A3 (fr) Regime progestatif-antiprogestatif

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999933540

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 559813

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999933540

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999933540

Country of ref document: EP